多克隆抗体采用人f KBP5蛋白羧基末端残基相对应的合成肽段免疫动物生产的。
Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues near the amino terminus of human FKBP5 protein.
该单克隆抗体是采用合成的人FIP200蛋白羧基末端附近的残基相对应的肽段免疫动物制备。
Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues near the carboxy terminus of human FIP200 protein.
该单克隆抗体是通过用重组蛋白免疫动物而制备的，该重组蛋白是人FGF受体2蛋白羧基末端区域的残基。
Monoclonal antibody is produced by immunizing animals with a recombinant protein corresponding to residues near the carboxy terminal region of human FGF receptor 2 protein.
此多克隆抗体经合成与人usp14蛋白羧基末端邻近氨基酸残基序列一致的肽段，免疫动物产生。
Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues near the carboxy terminus of human USP14 protein.
该单克隆抗体是通过用重组蛋白免疫动物而制备的，该重组蛋白包含人VEGF受体2蛋白羧基末端150氨基酸残基。
Monoclonal antibody is produced by immunizing animals with a recombinant protein containing the carboxy-terminal 150 amino acid residues of human VEGF receptor 2 protein.
此单克隆抗体由合成肽段免疫动物产生，该肽段与人ndrg1蛋白邻近羧基末端氨基酸残基序列一致。
Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues near the carboxy terminus of human NDRG1 protein.
此单克隆抗体由合成肽段免疫动物产生，该肽段与人ndrg1蛋白邻近羧基末端氨基酸残基序列一致。
Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues near the carboxy terminus of human NDRG1 protein.
应用推荐